Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Bone Health in Postmenopausal Women
NCT04864509Phase 4Unknown
- Sponsor
- Aarhus University
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in postmenopausal osteoporosis comparing Melatonin 10mg with Placebo (2 arms). Primary endpoint: Gene expression in marrow cells at 3 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT04864509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04864509.